Nixon Peabody Trust’s Gilead Sciences GILD Stock Holding History

Nixon Peabody Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Hold	11,564	–	–	0.1%	87
2026 Q1	$1.61M	Sell	11,564 -2,557	-18%	-$358K	0.13%	78
2025 Q4	$1.73M	Hold	14,121	–	–	0.13%	80
2025 Q3	$1.57M	Sell	14,121 -959	-6%	-$109K	0.11%	82
2025 Q2	$1.67M	Sell	15,080 -68	-0.4%	-$7.24K	0.13%	77
2025 Q1	$1.7M	Sell	15,148 -1,669	-10%	-$172K	0.14%	72
2024 Q4	$1.55M	Sell	16,817 -1,068	-6%	-$96.2K	0.13%	70
2024 Q3	$1.5M	Sell	17,885 -1,015	-5%	-$77.4K	0.12%	64
2024 Q2	$1.3M	Sell	18,900 -2,000	-10%	-$133K	0.12%	63
2024 Q1	$1.53M	Sell	20,900 -250	-1%	-$19.2K	0.14%	60
2023 Q4	$1.71M	Buy	+21,150	New	+$1.65M	0.19%	54

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Nixon Peabody Trust's GILD Position: Q2 2026 in Review

Nixon Peabody Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 11,564 shares worth $1.46M. The position accounts for 0.1% of the portfolio, ranked #87.

Nixon Peabody Trust first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.73M in Q4 2025. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Nixon Peabody Trust held 11,564 shares of Gilead Sciences worth $1.46M as of Q2 2026.
Nixon Peabody Trust left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.1% of Nixon Peabody Trust's portfolio in Q2 2026, its #87 holding.
Nixon Peabody Trust first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Nixon Peabody Trust's Gilead Sciences position peaked at $1.73M in Q4 2025.
837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.